We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

SkinBioTherapeutics plc (SBTX) Ord GBP0.01

Sell:65.00p Buy:66.00p 0 Change: 2.00p (3.17%)
Market closed Prices as at close on 22 October 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:65.00p
Buy:66.00p
Change: 2.00p (3.17%)
Market closed Prices as at close on 22 October 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:65.00p
Buy:66.00p
Change: 2.00p (3.17%)
Market closed Prices as at close on 22 October 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

SkinBioTherapeutics PLC is a life science company focused on skin health. The Company’s platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to skin. The Company’s SkinBiotix platform can improve the barrier effect of skin models, improve repair and reduce bacterial load. It focuses on three specific skin healthcare sectors: cosmetics, infection control and eczema. In each of these areas, the Company plans to exemplify its technology in human studies. The Company’s program is focused on the application of the Skinbiotix platform in managing sensitive skin in the cosmetics industry. SkinBiotix increases the rate of skin healing in response to injury.

Contact details

Address:
15 1 Silk House, Park Green
MACCLESFIELD
SK11 7QJ
United Kingdom
Telephone:
+44 (0161) 4682760
Website:
www.skinbiotherapeutics.com/

Important dates

Future events
There are no future events available.
Past events
AGM 29 December 2020 29/12/20
Annual report 04 December 2020 04/12/20
Final results 04 December 2020 04/12/20
General meeting 30 October 2020 30/10/20

General stock information

EPIC:
SBTX
ISIN:
GB00BF33H870
Market cap:
£101.91 million
Shares in issue:
156.78 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Stuart Ashman
    Chief Executive Officer, Executive Director
  • Douglas Quinn
    Chief Financial Officer, Executive Director, Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.